New breakthrough in fight against devastating disease that kills 90K a year
A breakthrough treatment has made significant progress, showing promising results in decreasing recurrence and death from a devastating disease. Led by researchers from NYU Langone Health and its Perlmutter Cancer Center, the landmark international study looked at the effects of anti-cancer medicine sacituzumab tirumotecan (sac-TMT) compared to standard chemotherapy drugs. The results of the phase … Read more